Delivery Order SPE2DR25D3301-SPE2DR26F18CU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packages) under a firm fixed price contract type. This award, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. The...
- The Defense Logistics Agency has awarded a delivery order valued at $11,236.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packages). This firm fixed-price delivery order, issued on October 29, 2025, with an ultimate completion date of November 20, 2025, represents a non-competitive, non-set-aside award to the pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) under a firm fixed-price contract. The order, issued on April 23, 2025, with an ultimate completion date of May 14, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and fulfills this delivery order as a child contract under a...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Tagrisso 80 mg tablets (30-count packaging). This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The order is scheduled for completion by December 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,662.57 on September 16, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 7, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a delivery order valued at $10,641.07 to AmerisourceBergen Drug Corp for the supply of Tagrisso 40 mg tablets (30-count units) on November 7, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price, non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on September 11, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price contract, classified as a non-set-aside competitive award, represents a continuation of the vendor's ongoing pharmaceutical supply relationship with the federal government. The product will be delivered to AmerisourceBergen's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $21,325.14 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on August 25, 2025, with completion scheduled for September 16, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, supports federal medical procurement needs through AmerisourceBergen's extensive pharmaceutical distribution network. The contractor will perform this delivery order from its...
- The Defense Logistics Agency awarded a $11,236.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Tagrisso 80 mg tablets (30-count). The contract will be performed at the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of December 1, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at approximately $32,000 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of August 15, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18CUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $22,473.42 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packaging) on November 17, 2025. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and no set-aside designation was utilized. The award represents a competitive procurement action supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal healthcare procurement needs across military and veteran systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion master vehicle extending through December 2026. The IDC functions as a comprehensive global pharmaceutical support contract enabling the supply of a broad range of pharmaceutical products, medical supplies, brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The underlying contract vehicle supports federal customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through a flexible procurement mechanism aligned with the Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.5k | 11/17/25 |